Janney Montgomery Scott’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$745K Sell
30,283
-13,018
-30% -$301K ﹤0.01% 2115
2026
Q1
$1.04M Sell
43,301
-2,939
-6% -$71.8K ﹤0.01% 1633
2025
Q4
$1.05M Buy
46,240
+3,311
+8% +$72.1K ﹤0.01% 1695
2025
Q3
$865K Buy
42,929
+1,455
+4% +$24.4K ﹤0.01% 1795
2025
Q2
$592K Sell
41,474
-416
-1% -$4.86K ﹤0.01% 1909
2025
Q1
$440K Buy
41,890
+683
+2% +$7.73K ﹤0.01% 2076
2024
Q4
$499K Sell
41,207
-16,286
-28% -$213K ﹤0.01% 2002
2024
Q3
$845K Sell
57,493
-7,370
-11% -$103K ﹤0.01% 1619
2024
Q2
$936K Buy
64,863
+885
+1% +$14.1K ﹤0.01% 1483
2024
Q1
$1.04M Buy
63,978
+2,659
+4% +$41.6K ﹤0.01% 1501
2023
Q4
$913K Buy
+61,319
New +$695K ﹤0.01% 1496
2023
Q3
Sell
-98,004
Closed -$986K 2630
2023
Q2
$986K Buy
98,004
+46,425
+90% +$431K ﹤0.01% 1420
2023
Q1
$485K Buy
51,579
+27,450
+114% +$324K ﹤0.01% 1749
2022
Q4
$295K Sell
24,129
-8,868
-27% -$111K ﹤0.01% 2141
2022
Q3
$409K Sell
32,997
-173,088
-84% -$3.03M ﹤0.01% 1817
2022
Q2
$4.05M Sell
206,085
-6,732
-3% -$159K 0.02% 664
2022
Q1
$5.55M Buy
212,817
+4,254
+2% +$113K 0.02% 568
2021
Q4
$5.92M Sell
208,563
-5,869
-3% -$183K 0.02% 573
2021
Q3
$6.84M Buy
214,432
+2,965
+1% +$99.5K 0.03% 502
2021
Q2
$7.34M Sell
211,467
-9,248
-4% -$305K 0.03% 463
2021
Q1
$6.5M Buy
220,715
+27,948
+14% +$860K 0.03% 459
2020
Q4
$5.91M Buy
192,767
+58,462
+44% +$1.78M 0.03% 491
2020
Q3
$3.75M Buy
134,305
+12,307
+10% +$312K 0.02% 572
2020
Q2
$2.62M Buy
121,998
+25,376
+26% +$561K 0.02% 670
2020
Q1
$2.16M Buy
96,622
+13,675
+16% +$375K 0.02% 669
2019
Q4
$2.44M Sell
82,947
-9,195
-10% -$250K 0.02% 716
2019
Q3
$2.45M Buy
92,142
+8,798
+11% +$264K 0.02% 676
2019
Q2
$2.82M Sell
83,344
-654
-0.8% -$21.2K 0.02% 600
2019
Q1
$2.69M Buy
83,998
+10,635
+14% +$327K 0.02% 599
2018
Q4
$2.31M Sell
73,363
-5,964
-8% -$195K 0.02% 593
2018
Q3
$2.77M Buy
+79,327
New +$2.79M 0.02% 590

Other funds holding ELAN

Janney Montgomery Scott's ELAN Position: Q2 2026 in Review

Janney Montgomery Scott reduced its Elanco Animal Health (ELAN) stake by 30% in Q2 2026, selling an estimated $301K and leaving 30,283 shares worth $745K. The position accounts for ﹤0.01% of the portfolio, ranked #2115.

Janney Montgomery Scott first reported a position in ELAN in Q3 2018 and has held it in 31 quarters since. The position peaked at $7.34M in Q2 2021. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Janney Montgomery Scott held 30,283 shares of Elanco Animal Health worth $745K as of Q2 2026.
  • Janney Montgomery Scott sold 13,018 Elanco Animal Health shares in Q2 2026, an estimated $301K.
  • Elanco Animal Health made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #2115 holding.
  • Janney Montgomery Scott first reported a position in Elanco Animal Health in Q3 2018 and has held it in 31 quarters since.
  • Janney Montgomery Scott's Elanco Animal Health position peaked at $7.34M in Q2 2021.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.